PetMed Express (PETS) Projected to Post Earnings on Tuesday

PetMed Express (NASDAQ:PETS - Get Free Report) is expected to issue its Q4 2025 quarterly earnings data after the market closes on Tuesday, June 10th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $54.00 million for the quarter.

PetMed Express Price Performance

Shares of PETS traded down $0.01 during midday trading on Friday, reaching $3.96. The stock had a trading volume of 107,216 shares, compared to its average volume of 268,033. PetMed Express has a 1-year low of $2.90 and a 1-year high of $6.85. The company's fifty day simple moving average is $3.54 and its two-hundred day simple moving average is $4.33. The company has a market cap of $81.80 million, a price-to-earnings ratio of 396.40 and a beta of 0.81.

Insiders Place Their Bets

In other news, major shareholder Silvercape Investments Ltd acquired 7,401 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was acquired at an average price of $3.95 per share, with a total value of $29,233.95. Following the completion of the transaction, the insider now directly owns 2,307,719 shares in the company, valued at approximately $9,115,490.05. This represents a 0.32% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Sandra Yvette Campos sold 60,463 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $3.31, for a total transaction of $200,132.53. Following the transaction, the chief executive officer now directly owns 578,524 shares of the company's stock, valued at $1,914,914.44. This trade represents a 9.46% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On PetMed Express

An institutional investor recently raised its position in PetMed Express stock. Goldman Sachs Group Inc. grew its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 59.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,209 shares of the company's stock after buying an additional 12,360 shares during the quarter. Goldman Sachs Group Inc. owned 0.16% of PetMed Express worth $139,000 at the end of the most recent quarter. Institutional investors own 73.33% of the company's stock.

Analyst Ratings Changes

Several research analysts have issued reports on PETS shares. Wall Street Zen downgraded shares of PetMed Express from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Morgan Stanley lowered their price objective on shares of PetMed Express from $3.50 to $3.20 and set an "underweight" rating on the stock in a research report on Thursday, April 17th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.